EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$8.99
-2.29%
Mkt Cap $587.95M
Analyst Ratings
Buy
0
Hold
0
Sell
3
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-44.4%
Consensus $5.00 vs current $8.99